Abbott LaboratoriesABT -0.04%80 Dividend Yield % is 2.71% as of Jun. 25, 2026, which is 57% above its 10-year median of 1.73. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued). Among 327 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 63.61% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Abbott Laboratories is 2.71%.
Good Sign:
Abbott Laboratories stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for Abbott Laboratories's Dividend Yield % or its related term are showing as below:
ABT'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.12 Med: 1.73 Max: 2.85
Current: 2.71
During the past 13 years, the highest Dividend Yield of Abbott Laboratories was 2.85%. The lowest was 1.12%. And the median was 1.73%.
ABT's Dividend Yield % is ranked better than 63.61% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 1.97
vs ABT: 2.71
During the past 12 months, Abbott Laboratories's average Dividends Per Share Growth Rate was 7.10% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 7.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 9.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 10.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Abbott Laboratories was 22.90% per year. The lowest was -31.20% per year. And the median was 10.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Abbott Laboratories Dividend Yield % Related Terms
Abbott Laboratories Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Abbott Laboratories Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.630000
2026-04-15
2026-04-15
2026-05-15
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.630000
2026-01-15
2026-01-15
2026-02-13
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.590000
2025-10-15
2025-10-15
2025-11-17
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.590000
2025-07-15
2025-07-15
2025-08-15
Cash Dividend
quarterly
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Abbott Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (ABT) has a Dividend Yield % of 2.71% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Abbott Laboratories and its competitors. This is 57% above median its historical median of 1.73. Over the past decade, Abbott Laboratories' Dividend Yield % has ranged from 1.12 to 2.85. According to the industry distribution chart, Abbott Laboratories ranks #119 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 36.4%.
Is Abbott Laboratories' Dividend Yield % too high?
Abbott Laboratories' current Dividend Yield % of 2.71% is 57% above median its 10-year median of 1.73. Over the past 10 years, this metric has ranged from a low of 1.12 to a high of 2.85. The Medical Devices & Instruments industry median Dividend Yield % is 1.97. Abbott Laboratories' value of 2.71% is 37.6% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #119 out of 327 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Dividend Yield % compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #119 out of 327 companies for Dividend Yield %. This puts Abbott Laboratories in the upper half of its industry. The industry median Dividend Yield % is 1.97. Abbott Laboratories' value of 2.71% is 37.6% above this benchmark. Historically, Abbott Laboratories' own Dividend Yield % has ranged from 1.12 to 2.85 over the past decade. While the company's 10-year median is 1.73 vs. the industry median of 1.97, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.97, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current Dividend Yield % of 2.71% is 37.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current Dividend Yield % is 2.71%, which is 57% above median its own 10-year median of 1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current Dividend Yield % is 2.71%, which is 57% above median its 10-year median of 1.73 and 37.6% above the Medical Devices & Instruments industry median of 1.97. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Dividend Yield % is 2.71% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49.
GuruFocus considers Abbott Laboratories to be Significantly Undervalued.
Key valuation signals for ABT:
Dividend Yield %: 2.71% (57% above median its 10-year median of 1.73)
GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
Industry Position: 37.6% above the Medical Devices & Instruments median (#119 of 327)
No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for ABT
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABT has been successfully added to your 
